Impact of Gestational COVID-19 on Neonatal Outcomes: Is Vertical Infection Possible?
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
pubmed:
2
4
2022
medline:
14
5
2022
entrez:
1
4
2022
Statut:
ppublish
Résumé
The vertical transmission of severe acute respiratory coronavirus-2 (SARS-CoV-2) remains highly debated. Here, we evaluated SARS-CoV-2-transmission in newborns with intrauterine conditions. This was a prospective, observational and multicentric study involving 13 Spanish hospitals included in the GEStational and NEOnatal-COVID cohort. Pregnant women with microbiologically confirmed SARS-CoV-2 infection during any trimester of pregnancy or delivery and their newborns were included from March to November 2020. Demographic, clinical and microbiological data were also obtained. Viral loads were analyzed in different maternal and newborn biological samples (placenta, breast milk and maternal blood; urine, meconium and newborn blood). A total of 177 newborns exposed to SARS-CoV-2 were included. Newborns were tested by reverse transcriptase-polymerase chain reaction using nasopharyngeal swabs within the first 24-48 hours of life and at 14 days of life. In total 5.1% were considered to have SARS-CoV-2 infection in the neonatal period, with 1.7% considered intrauterine and 3.4% intrapartum or early postnatal transmission cases. There were no differences in the demographic and clinical characteristics of the pregnant women and their newborns' susceptibility to infections in their perinatal history or background. Intrauterine transmission of SARS-CoV-2 is possible, although rare, with early postnatal transmission occurring more frequently. Most infected newborns remained asymptomatic or had mild symptoms that evolved well during follow-up. We did not find any maternal characteristics predisposing infants to neonatal infection. All infected newborn mothers had acute infection at delivery.Although there was no presence of SARS-CoV2 in cord blood or breast milk samples, SARS-CoV-2 viral load was detected in urine and meconium samples from infected newborns.
Sections du résumé
BACKGROUND
The vertical transmission of severe acute respiratory coronavirus-2 (SARS-CoV-2) remains highly debated. Here, we evaluated SARS-CoV-2-transmission in newborns with intrauterine conditions.
METHODS
This was a prospective, observational and multicentric study involving 13 Spanish hospitals included in the GEStational and NEOnatal-COVID cohort. Pregnant women with microbiologically confirmed SARS-CoV-2 infection during any trimester of pregnancy or delivery and their newborns were included from March to November 2020. Demographic, clinical and microbiological data were also obtained. Viral loads were analyzed in different maternal and newborn biological samples (placenta, breast milk and maternal blood; urine, meconium and newborn blood).
RESULTS
A total of 177 newborns exposed to SARS-CoV-2 were included. Newborns were tested by reverse transcriptase-polymerase chain reaction using nasopharyngeal swabs within the first 24-48 hours of life and at 14 days of life. In total 5.1% were considered to have SARS-CoV-2 infection in the neonatal period, with 1.7% considered intrauterine and 3.4% intrapartum or early postnatal transmission cases. There were no differences in the demographic and clinical characteristics of the pregnant women and their newborns' susceptibility to infections in their perinatal history or background.
CONCLUSIONS
Intrauterine transmission of SARS-CoV-2 is possible, although rare, with early postnatal transmission occurring more frequently. Most infected newborns remained asymptomatic or had mild symptoms that evolved well during follow-up. We did not find any maternal characteristics predisposing infants to neonatal infection. All infected newborn mothers had acute infection at delivery.Although there was no presence of SARS-CoV2 in cord blood or breast milk samples, SARS-CoV-2 viral load was detected in urine and meconium samples from infected newborns.
Identifiants
pubmed: 35363644
doi: 10.1097/INF.0000000000003518
pii: 00006454-202206000-00004
pmc: PMC9083309
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
466-472Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Schwartz DA. The effects of pregnancy on women with COVID-19: maternal and infant outcomes. Clin Infect Dis. 2020;71:2042–2044.
Mei Y, Luo D, Wei S, et al. Obstetric management of COVID-19 in pregnant women. Front Microbiol. 2020;11:1–9.
Schwartz DA, Graham AL. Potential maternal and infant outcomes from coronavirus 2019-NCOV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12:1–16.
Blumberg DA, Underwood MA, Hedriana HL, et al. Vertical transmission of SARS-CoV-2: what is the optimal definition? Am J Perinatol. 2020;37:769–772.
World Health Organization. Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2. Living guidance. February 8, 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-mother-to-child-transmission-2021.1
Auriti C, De Rose DU, Tzialla C, et al. Vertical transmission of SARS-CoV-2 (COVID-19): are hypotheses more than evidences? Am J Perinatol. 2020;37(S 02):S31–S38.
Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obs Gynecol [Internet]. 2020;223:111.e1111.e14.
Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet. 2021;304:5–38.
Sánchez-Luna M, Colomer BF, de Alba Romero C, et al. Neonates born to mothers with COVID-19: data from the Spanish society of neonatology registry. Pediatrics. 2021;147:e2020015065.
Walker KF, O’Donoghue K, Grace N, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG. 2020;127:1324–1336.
Villar J, Ariff S, Gunier RB, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021;175:817–826.
Fernández Colomer B, Sánchez-Luna M, de Alba Romero C, et al. Neonatal infection due to SARS-CoV-2: An Epidemiological Study in Spain. Front Pediatr. 2020;8:1–9.
Bwire GM, Njiro BJ, Mwakawanga DL, et al. Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: a living systematic review. J Med Virol. 2021;93:1361–1369.
Di Toro F, Gjoka M, Di Lorenzo G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27:36–46.
Kotlyar AM, Grechukhina O, Chen A, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021;224:35–53.
Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet. 2021;303:337–345.
Marín Gabriel MA, Reyne Vergeli M, Caserío Carbonero S, et al.; Neo-COVID-19 Research Group. Maternal, perinatal and neonatal outcomes with COVID-19: a multicenter study of 242 pregnancies and their 248 infant newborns during their first month of life. Pediatr Infect Dis J. 2020;39:e393–e397.
Li N, Han L, Peng M, et al. Maternal and neonatal outcomes of pregnant women with Coronavirus Disease 2019 (COVID-19) pneumonia: a case-control study. Clin Infect Dis. 2020;71:2035–2041.
Edlow AG, Li JZ, Collier AY, et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open. 2020;3:e2030455.
Levitan D, London V, McLaren RA, et al. Histologic and immunohistochemical evaluation of 65 placentas from women with polymerase chain reaction-proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Arch Pathol Lab Med. 2021;145:648–656.
Zhang P, Heyman T, Greechan M, et al. Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers. J Matern Fetal Neonatal Med. 2021;28:1–9.
Sociedad Española de Neonatología (Spanish Society of Neonatology). Recommendations for management of newborns for SARS-CoV-2 infection. [Internet]. [cited 2021 Jun 15]. Available at: https://www.seneo.es/images/site/noticias/home/Recomendaciones_SENeo_COVID-19_v6_eng.pdf
World Health Organization. Breastfeeding and COVID-19. Scientific brief. 2020. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Breastfeeding-2020.1
Puopolo KM, Hudak ML, Kimberlin DW, et al. Initial Guidance: Management of Infants Born to Mothers With COVID-19. American Academy of Pediatrics Committee on Fetus and Newborn, Section on Neonatal Perinatal Medicine, and Committee on Infectious Diseases; 2020.
Lackey KA, Pace RM, Williams JE, et al. SARS-CoV-2 and human milk: What is the evidence? Matern Child Nutr. 2020;16:e13032.
Tam PCK, Ly KM, Kernich ML, et al. Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021;72:128–130.
Groß R, Conzelmann C, Müller JA, et al. Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020;395:1757–1758.
Pace RM, Williams JE, Järvinen KM, et al. Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19. mBio. 2021;12:e03192–e03120.
Jones DL, Baluja MQ, Graham DW, et al. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. Sci Total Environ. 2020;749:141364.
Cai J, Xu J, Lin D, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020;71:1547–1551.